ArticlebioRxiv : the preprint server for biology2023
Variants in the
Abstract readPreprint
In one paragraph
Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Novel insight into CFTR gene's single nucleotide variants classification via in-silico analysis of a conserved site.Journal of computer-aided molecular design · 2025Article
- Treponema denticola major surface protein (Msp): a key player in periodontal pathogenicity and immune evasion.Archives of microbiology · 2025Review
Corrections and comments
- Updated by
Authors and funding
79 authors.
Mandi M WileyGenes and Human Disease Research Program, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA.
Bhuwan KhatriGenes and Human Disease Research Program, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA.
Michelle L JoachimsGenes and Human Disease Research Program, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA.
Kandice L TessneerGenes and Human Disease Research Program, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA.
Anna M StolarczykGenes and Human Disease Research Program, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA.
Astrid RasmussenGenes and Human Disease Research Program, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA.
Juan-Manuel AnayaUniversidad del Rosario, Bogotá, Colombia.
Lara A AqrawiDepartment of Health Sciences, Kristiania University College, Oslo, Norway.
Sang-Cheol BaeHanyang University, Seoul, Republic of Korea.
Eva BaecklundUppsala University, Uppsala, Sweden.
Albin BjörkKarolinska Institutet, Solna, Sweden.
Johan G BrunUniversity of Bergen, Bergen, Norway.
Sara Magnusson BucherÖrebro University, Örebro, Sweden.
Nick DandKing's College London, London, United Kingdom.
Maija-Leena ElorantaUppsala University, Uppsala, Sweden.
Fiona EngelkeHannover Medical School, Hannover, Germany.
Helena Forsblad-d'EliaUniversity of Gothenburg, Gothenburg, Sweden.
Cecilia FugmannUppsala University, Uppsala, Sweden.
Stuart B GlennGenes and Human Disease Research Program, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA.
Chen GongKing's College London, London, United Kingdom.
Jacques-Eric GottenbergStrasbourg University Hospitals, Strasbourg, France.
Daniel HammenforsHaukeland University Hospital, Bergen, Norway.
Juliana Imgenberg-KreuzUppsala University, Uppsala, Sweden.
Janicke Liaaen JensenUniversity of Oslo, Norway.
Svein Joar Auglænd JohnsenStavanger University Hospital, Stavanger, Norway.
Malin V JonssonUniversity of Bergen, Bergen, Norway.
Jennifer A KellyGenes and Human Disease Research Program, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA.
Sharmily KhanamArthritis and Clinical Immunology Research Program, OMRF, Oklahoma City, Oklahoma, USA.
Kwangwoo KimKyung Hee University, Seoul, Republic of Korea.ORCID 0000-0001-8926-6216
Marika KvarnströmKarolinska Institutet, Solna, Sweden.
Thomas MandlLund University, Malmö, Sweden.
Javier MartínInstituto de Biomedicina y Parasitología López-Neyra, Granada, Spain.
David L MorrisKing's College London, London, United Kingdom.ORCID 0000-0002-1754-8932
Gaetane NocturneUniversité Paris-Saclay, Paris, France.
Katrine Brække NorheimStavanger University Hospital, Stavanger, Norway.
Peter OlssonLund University, Malmö, Sweden.
Øyvind PalmOslo University Hospital, Oslo, Norway.
Jacques-Olivier PersLBAI, UMR1227, University of Brest, Inserm, Brest, France.
Nelson L RhodusUniversity of Minnesota Medical School, Minnesota, USA.
Christopher SjöwallLinköping University, Linköping, Sweden.
Kathrine SkarsteinUniversity of Bergen, Bergen, Norway.
Kimberly E TaylorUniversity of California San Francisco, San Francisco, California, USA.
Phil TomblesonKing's College London, London, United Kingdom.
Gudny Ella ThorlaciusKarolinska Institutet, Solna, Sweden.
Swamy VenuturupalliCedars-Sinai Medical Center, Los Angeles, California, USA.
Edward M VitalUniversity of Leeds, Leeds, United Kingdom.ORCID 0000-0003-1637-4755
Daniel J WallaceCedars-Sinai Medical Center, Los Angeles, California, USA.
Kiely M GrundahlGenes and Human Disease Research Program, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA.
Lida RadfarUniversity of Oklahoma College of Dentistry, Oklahoma City, Oklahoma, USA.
Michael T BrennanAtrium Health Carolinas Medical Center, Charlotte, North Carolina, USA.
Judith A JamesArthritis and Clinical Immunology Research Program, OMRF, Oklahoma City, Oklahoma, USA.
R Hal ScofieldArthritis and Clinical Immunology Research Program, OMRF, Oklahoma City, Oklahoma, USA.
Patrick M GaffneyGenes and Human Disease Research Program, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA.
Lindsey A CriswellUniversity of California San Francisco, San Francisco, California, USA.
Roland JonssonUniversity of Bergen, Bergen, Norway.
Silke AppelUniversity of Bergen, Bergen, Norway.
Per ErikssonLinköping University, Linköping, Sweden.
Simon J BowmanUniversity Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
Roald OmdalUniversity of Bergen, Bergen, Norway.
Lars RönnblomUppsala University, Uppsala, Sweden.
Blake M WarnerNational Institute of Dental and Craniofacial Research, Bethesda, Maryland, USA.
Maureen RischmuellerUniversity of Adelaide, Adelaide, South Australia.
Torsten WitteHannover Medical School, Hannover, Germany.
A Darise FarrisArthritis and Clinical Immunology Research Program, OMRF, Oklahoma City, Oklahoma, USA.ORCID 0000-0003-3009-2017
Xavier MarietteUniversité Paris-Saclay, Paris, France.
Caroline H ShiboskiUniversity of California San Francisco, San Francisco, California, USA.
Sjögren’s International Collaborative Clinical Alliance (SICCA)
Marie Wahren-HerleniusKarolinska Institutet, Solna, Sweden.
Marta E Alarcón-RiquelmeKarolinska Institutet, Solna, Sweden.
PRECISESADS Clinical Consortium
Wan-Fai NgNIHR Newcastle Biomedical Research Centre and NIHR Newcastle Clinical Research Facility, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom.
UK Primary Sjögren’s Syndrome Registry
Kathy L SivilsArthritis and Clinical Immunology Research Program, OMRF, Oklahoma City, Oklahoma, USA.
Joel M GuthridgeArthritis and Clinical Immunology Research Program, OMRF, Oklahoma City, Oklahoma, USA.ORCID 0000-0002-9308-237X
Indra AdriantoCenter for Bioinformatics, Department of Public Health Sciences, Henry Ford Health, Detroit, Michigan, USA.
Timothy J VyseKing's College London, London, United Kingdom.
Betty P TsaoMedical University of South Carolina, Charleston, South Carolina, USA.
Gunnel NordmarkUppsala University, Uppsala, Sweden.
Christopher J LessardGenes and Human Disease Research Program, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA.ORCID 0000-0003-2440-3843
Funding
Targeting the p53 pathway for reversal of oral premalignancyP50CA097007 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LEE, HO-YOUNG · 2002 to 2012
$26.1MUT M.D. Anderson Cancer Center SPORE in MelanomaP50CA093459 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI GRIMM, ELIZABETH A · 2004 to 2014
$23.7MOklahoma Rheumatic Disease Research Cores Center (Overall Application)P30AR073750 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI JUDITH A JAMES · 2018 to 2026
$8.5MRESOURCE-BASED CENTER FOR THE ADVANCEMENT OF PRECISION MEDICINE IN RHEUMATOLOGYP30AR070155 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Mary C Nakamura · 2016 to 2026
$8.2MPathogenic B Cells in Sjogren's SyndromeP50AR060804 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI SIVILS, KATHY L. · 2011 to 2015
$7.9MCreating a National Resource for Genetic Research in Behavioral & Health SciencesRC2AG036495 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WEIR, DAVID R. · 2009 to 2010
$7.4MGenome Wide Association Coordinating CenterU01HG004446 · NHGRI · UNIVERSITY OF WASHINGTON · PI WEIR, BRUCE S. · 2007 to 2011
$6.6MMolecular Epidemiology of Head and Neck CancerR01ES011740 · NIEHS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI WEI, QINGYI · 2001 to 2012
$6.3MExpanding a National Resource for Genetic Research in Behavioral & Health ScienceRC4AG039029 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WEIR, DAVID R. · 2010 to 2010
$6.0MSjögren's International Collaborative Clinical Alliance Next Generation Studies (SICCA-NextGen)U01DE028891 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SHIBOSKI, CAROLINE HELENE · 2020 to 2024
$4.0MDiscovery and Characterization of Genetic Risk Loci in Sjogren's SyndromeR01AR073855 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI LESSARD, CHRISTOPHER J · 2020 to 2024
$3.7MTransancestral fine mapping and functional dissection of autophagy-related SLE risk lociR01AR071410 · NIAMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI LESSARD, CHRISTOPHER J, TSAO, BETTY P · 2018 to 2022
$3.5MIntramural NIH HHS Z01 DE000704NCI NIH HHS P50 CA093459NCI NIH HHS P50 CA097007NCI NIH HHS R01 CA133996NHGRI NIH HHS HHSN268200782096CNHGRI NIH HHS U01 HG004446NHLBI NIH HHS HHSN268201100011CNHLBI NIH HHS HHSN268201100011INHLBI NIH HHS HHSN268201200008CNHLBI NIH HHS HHSN268201200008INIAID NIH HHS UM1 AI144292NIAMS NIH HHS P30 AR070155NIAMS NIH HHS P30 AR073750NIAMS NIH HHS P50 AR060804NIAMS NIH HHS R01 AR065953NIAMS NIH HHS R01 AR071410NIAMS NIH HHS R01 AR071947NIAMS NIH HHS R01 AR073855NIAMS NIH HHS R01 AR074310NIAMS NIH HHS R21 AR079089NIAMS NIH HHS R33 AR076803NIAMS NIH HHS R61 AR076803NIA NIH HHS RC2 AG036495NIA NIH HHS RC4 AG039029NIDCR NIH HHS N01 DE032636NIDCR NIH HHS R03 DE029800NIDCR NIH HHS U01 DE028891NIEHS NIH HHS R01 ES011740
Abstract
Fine mapping and bioinformatic analysis of the
Indexed as
chromatin regulatory networkC-X-C motif chemokine receptor 5CXCR5DDX6DEAD-Box helicase 6lnc-PHLDB1-1Sjögren’s DiseaseSLEsystemic lupus erythematosus
Identifiers
What Socratic holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.